ACAAI 2022
Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab
Investigators assessed the annualized asthma exacerbation rate (AAER) and the annualized rate of asthma exacerbations requiring hospitalization over 52 weeks.